Does creatine supplementation improve cognition?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Creatine Supplementation and Cognitive Effects

Creatine supplementation may provide modest cognitive benefits, particularly for memory and attention, though the evidence remains limited and effects appear small. Based on the most recent and highest-quality evidence, creatine monohydrate shows promise for supporting brain function, but should not yet be considered an established cognitive enhancer for general populations.

Evidence from Sports Medicine Guidelines

The UEFA Expert Group statement on elite football nutrition 1 explicitly recognizes that creatine "may also support brain function" alongside its established benefits for high-intensity exercise performance. The recommended protocol involves:

  • Loading phase: 20 g/day (divided into four 5g doses) for 5-7 days
  • Maintenance phase: 3-5 g/day as a single dose
  • Important consideration: Expect 1-2 kg body mass increase after loading, with no negative health effects following appropriate protocols

This guideline acknowledges cognitive support as a secondary benefit, though the primary focus remains athletic performance.

Recent Clinical Evidence

Human Studies Show Mixed but Promising Results

The most recent pilot trial in Alzheimer's disease patients 2 demonstrated that 20 g/day of creatine monohydrate for 8 weeks increased brain total creatine by 11% and was associated with improvements in global cognition (p=0.02), fluid cognition (p=0.004), and specific cognitive domains. This represents the strongest recent human evidence, though the sample size was small (n=20) and lacked a control group.

A 2024 systematic review and meta-analysis 3 of 16 RCTs (492 participants) found:

  • Significant positive effects on memory (SMD=0.31,95% CI: 0.18-0.44)
  • Improved attention time (SMD=-0.31,95% CI: -0.58 to -0.03)
  • Enhanced processing speed (SMD=-0.51,95% CI: -1.01 to -0.01)
  • No significant improvements in overall cognitive function or executive function

The GRADE assessment indicates moderate certainty for memory benefits but low certainty for other cognitive domains.

Who May Benefit Most

Subgroup analyses 3 revealed creatine supplementation was more beneficial in:

  • Individuals with existing diseases (vs. healthy populations)
  • Adults aged 18-60 years (vs. older adults)
  • Females (vs. males)

This sex difference is critical—one rodent study 4 showed female animals demonstrated cognitive benefit while males showed a trend toward harm, paralleled by sex-divergent bioenergetic responses in human trials.

Critical Limitations and Caveats

Blood-Brain Barrier Challenge

The fundamental limitation is whether supplemented creatine crosses the blood-brain barrier in sufficient amounts 5. While some studies show modest brain creatine increases (11% in the AD pilot trial 2), methodological constraints and individual variability limit firm conclusions. A 2024 systematic review 6 concluded that research "fails to support the theoretical basis for an effect on cognition" despite showing increased brain creatine content.

Contradictory Evidence

The largest controlled study to date 7—a preregistered, double-blind, placebo-controlled crossover trial with 123 participants using 5 g/day for 6 weeks—found:

  • Creatine effect bordered significance for backward digit span (p=0.064) but not for Raven's matrices (p=0.327)
  • No indication of improvement on eight exploratory cognitive tasks
  • Side effects reported significantly more often with creatine than placebo (p=0.002, RR=4.25)

This suggests that at standard maintenance doses, cognitive effects may be minimal or absent in healthy adults.

Methodological Issues

Multiple reviews 4, 6, 5 highlight critical gaps:

  • Absence of adequately powered RCTs in dementia populations
  • Lack of standardized dosing protocols for brain penetrance
  • Insufficient understanding of optimal duration and formulation
  • Need for sex-stratified analyses given divergent responses

Practical Recommendations

For Healthy Adults Seeking Cognitive Enhancement

The evidence does not currently support routine creatine supplementation solely for cognitive benefits in healthy populations. The effect sizes are small, inconsistent across studies, and may not translate to clinically meaningful improvements in daily function.

For Specific Populations

Consider creatine supplementation (with appropriate counseling about limited evidence) in:

  1. Vegetarians/vegans with dietary creatine deficiency
  2. Older adults with mild cognitive concerns (though evidence is preliminary)
  3. Individuals with diagnosed Alzheimer's disease as part of research protocols or off-label use after informed discussion
  4. Athletes already using creatine for performance who may receive secondary cognitive benefits

Dosing Strategy

If pursuing supplementation for cognitive purposes:

  • Standard approach: 3-5 g/day maintenance dose (skip loading phase to avoid body mass increase)
  • Higher-dose approach (based on AD pilot trial 2): 20 g/day, though this requires medical supervision and monitoring
  • Duration: Minimum 4-6 weeks to assess response
  • Monitoring: Track subjective cognitive changes; consider discontinuation if no perceived benefit after 8-12 weeks

Safety Considerations

Creatine supplementation increases serum creatinine levels 8 (MD 0.14 mg/dL) and reduces GFR estimated by creatinine-based methods (MD -10.75 mL/min), though this likely reflects altered creatinine metabolism rather than kidney injury. No changes occur when GFR is assessed by Cr-EDTA, indicating these are measurement artifacts rather than true renal dysfunction.

Clinical Bottom Line

Creatine supplementation represents a hypothesis rather than an established clinical practice for cognitive enhancement 5. While mechanistically plausible and showing preliminary positive signals—particularly for memory in specific populations—the evidence remains insufficient to recommend it as a primary cognitive intervention. The modest potential benefits must be weighed against cost, side effects (reported 4.25 times more frequently than placebo 7), and the reality that effects may be minimal or absent in many individuals.

For patients already using creatine for athletic performance, the potential secondary cognitive benefits provide additional rationale for continued use. For those considering it solely for cognition, a frank discussion about limited evidence, small effect sizes, and individual variability is essential before initiating supplementation.

References

Related Questions

What are the effects of exogenous creatine supplementation on performance, cognition, and safety?
Is there evidence that a 10 mg dose of creatine improves cognitive function?
Does creatine supplementation have benefits for early cognitive decline?
Is a single 25‑gram dose of creatine monohydrate safe for enhancing cognitive function before an exam in a healthy adult?
Is it safe for me to start creatine supplementation for cognitive enhancement while I am taking oxcarbazepine 300 mg daily and olanzapine 5 mg daily?
Given that the patient feels under the weather and fatigued but has no clinical signs of septic arthritis, does this alter the management plan for his ankle arthritis?
In which clinical scenarios is it appropriate to administer a rescue corticosteroid course as early as seven days after a prior dose?
In a patient with normal thyroid‑stimulating hormone, vitamin B12, folate, and vitamin D levels, persistent fatigue and intermittent dizziness, and a complete blood count showing neutrophils 56.9 %, lymphocytes 35.1 % (absolute lymphocyte count 4,001 µL) with mild leukocytosis, what is the appropriate next step in evaluation?
Is a T‑wave inversion of 2 mm or greater considered a significant finding requiring urgent evaluation?
What are the possible causes of elevated ammonia in a postoperative patient without known liver disease?
What is the recommended dosage and precautions for using meclizine to treat non‑positional peripheral vertigo in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.